(Total Views: 451)
Posted On: 03/25/2020 3:22:02 PM
Post# of 153986
Gilead to withdraw Orphan Drug tag for remdesivir; shares down 3%
Mar. 25, 2020 1:24 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
Gilead Sciences (GILD -3.1%) has submitted a request to the FDA to rescind Orphan Drug status for antiviral remdesivir for COVID-19, a designation granted by the agency only two days ago.
The company says it can maintain an expedited timeline for regulatory review without the designation which is intended to apply for diseases affecting no more than 200K Americans.
https://seekingalpha.com/news/3555135-gilead-...res-down-3
Mar. 25, 2020 1:24 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
Gilead Sciences (GILD -3.1%) has submitted a request to the FDA to rescind Orphan Drug status for antiviral remdesivir for COVID-19, a designation granted by the agency only two days ago.
The company says it can maintain an expedited timeline for regulatory review without the designation which is intended to apply for diseases affecting no more than 200K Americans.
https://seekingalpha.com/news/3555135-gilead-...res-down-3
(0)
(0)
